advanced search

Latest Issue

Prefilled Syringes & Injection Devices182

Issue No #182 Jan 2026  January 16th, 2026


Download PDF


Issue 182 - Jan 2026

Inside the magazine

ARE YOU STILL PIECING TOGETHER YOUR PREFILLABLE SYRINGE SYSTEM OR ARE YOU ALREADY FILLING IT?
PREFILLED SYRINGES
Dr Bettine Boltres
West Pharmaceutical Services
ARE YOU STILL PIECING TOGETHER YOUR PREFILLABLE SYRINGE SYSTEM OR ARE YOU ALREADY FILLING IT?
Dr Bettine Boltres introduces the West Synchrony™ prefillable syringe system, explaining how the device, as a single comprehensive package, minimises regulatory complications and delays.
TRENDS FOR 2026
EXPERT VIEW
Tom Oakley
TRENDS FOR 2026
A new reality is forming as we enter 2026 – it will not be “business as usual”. Geopolitical forces in the largest market for pharmaceuticals, the US, are likely to mean substantial changes. Here, Tom Oakley and Alex Vasiev cover those changes, the incretin juggernaut and the march of technical progress with “minitablet” dispensers, large-volume injectors and dual-chamber devices.
Interview: Enhancing Clinical Trials with CliniPilot<sup>®</sup> and Clear to Clinic™ Programme
INTERVIEW
Dr Carolina Canapè
Ypsomed
Interview: Enhancing Clinical Trials with CliniPilot® and Clear to Clinic™ Programme
Dr Carolina Canapè and Roger Lüscher talk with Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors support faster, more efficient and more effective clinical trials.
ACCELERATING PATIENT-CENTRIC THERAPIES FROM DEVELOPMENT TO DELIVERY
INDUSTRIALISATION
Justin Schroeder
PCI Pharma Services
ACCELERATING PATIENT-CENTRIC THERAPIES FROM DEVELOPMENT TO DELIVERY
Justin Schroeder outlines its product service offering to the drug delivery industry, including sterile fill-finish services, drug-device combination product development and testing, clinical and commercial device assembly, packaging, storage and distribution, among other services.
TIME TO MARKET: INCREASED CUSTOMER VALUE THROUGH GLOBAL RAMP-UP EXCELLENCE
PREFILLED SYRINGES
David Pircher
Baumann Medical
TIME TO MARKET: INCREASED CUSTOMER VALUE THROUGH GLOBAL RAMP-UP EXCELLENCE
David Pircher and Leander Moser discuss the advantages of having a global presence, which combines both local expertise and technical excellence with worldwide co-ordination of supply to deliver consistent and quality solutions.
Interview: Developing Wearable Injectors
INTERVIEW
Liat Shochat
EdgeOne Medical
Interview: Developing Wearable Injectors
Liat Shochat discusses her extensive experience in wearable drug delivery device development, covering the various challenges that arise from the inherent complexity of these devices, even with multiple successful wearable devices on the market, as well as the best way to engage with contract development organisations such as EdgeOne Medical.
EARLY AUTOMATION CONSIDERATIONS FOR THE DEVELOPMENT OF DRUG DELIVERY COMBINATION PRODUCTS
PREFILLED SYRINGES
Asmita Khanolkar
SMC Ltd
EARLY AUTOMATION CONSIDERATIONS FOR THE DEVELOPMENT OF DRUG DELIVERY COMBINATION PRODUCTS
Asmita Khanolkar and Al Neumann, uncover the manufacturing strategies that can be used to achieve design for automation, scale-up and sustainable solutions for clinical and commercial launch, describing the gains to be made in manufacturing efficiency when using small, automated work cells.
FRICTIONLESS ENGAGEMENT: HOW GX INMONIT™ CAN SIMPLIFY SELF-INJECTION AND STRENGTHENS PATIENT ADHERENCE
CONNECTIVITY
Giacomo Bruno
Gerresheimer
FRICTIONLESS ENGAGEMENT: HOW GX INMONIT™ CAN SIMPLIFY SELF-INJECTION AND STRENGTHENS PATIENT ADHERENCE
Dr Giacomo Bruno and Simon Buerdel consider the causes of patient non-adherence and its subsequent effects on healthcare systems, going on to present the solutions created by Gerresheimer to address the patient experience across treatment types.
TESTING AUTOINJECTORS ACCORDING TO ISO 11608-5 TO INCREASE RELIABILITY AND BOOST EFFICIENCY
PREFILLED SYRINGES
Wolfgang Moersch
ZwickRoell
TESTING AUTOINJECTORS ACCORDING TO ISO 11608-5 TO INCREASE RELIABILITY AND BOOST EFFICIENCY
Wolfgang Moersch discusses the role of automation in testing injection devices – including autoinjectors, pen injectors and on-body injectors – and how advanced testing software and robotics solutions can provide more accurate and consistent testing results.
SAFETY BY DESIGN FOR DRUG DELIVERY DEVICES
PREFILLED SYRINGES
Dr Stefan Schreiber
Scherdel Medtec North America
SAFETY BY DESIGN FOR DRUG DELIVERY DEVICES
Professor Stefan Schreiber, Dr Theo Wember and Sebastian Block discuss how using Design of Experiments methodology can provide insights into the manufacturing process of power springs that can enable manufacturers to more robustly control variables and produce more consistent outputs.
FROM CONCEPT TO SERIES PRODUCTION – ACCELERATING INDUSTRIALISATION IN MEDTECH
PREFILLED SYRINGES
Matthias Müller
Contexo
FROM CONCEPT TO SERIES PRODUCTION – ACCELERATING INDUSTRIALISATION IN MEDTECH
Matthias Müller and Sven Müller discuss Contexo and Probotec's combined approach to scaling drug-device combination products from laboratory prototypes to fully validated GMP commercial-scale production lines.
Interview: New But Not News – A Smooth Transition to USP <382> with Established Expertise
INTERVIEW
Dr Aurelie Rebuffet
BD (Becton Dickinson & Company)
Interview: New But Not News – A Smooth Transition to USP <382> with Established Expertise
Dr Aurélie Rebuffet and Virginie Jeymond, discuss the new requirements set out in the US Pharmacopeia (USP) Chapter <382>, including the shift towards assessing the drug-device combination product as a holistic whole and how ZebraSci and BD can support pharma companies in complying with USP <382>.
BUILDING STRATEGIC PARTNERSHIPS FOR EARLY-STAGE DRUG DELIVERY DEVICE TESTING
INJECTION
Landon Goldfarb
Instron
BUILDING STRATEGIC PARTNERSHIPS FOR EARLY-STAGE DRUG DELIVERY DEVICE TESTING
Landon Goldfarb considers the importance of relationships between formulation and delivery teams for pharmaceutical innovation, highlighting a framework to differentiate between an equipment supplier and a testing partner, outlining the system capabilities and organisational competencies required to create effective early device-development teams.
REDEFINING THE ROLE OF PACKAGING IN A DEMANDING PHARMACEUTICAL LANDSCAPE
CONFERENCE SHOWCASE
Sherma Ellis Daal
REDEFINING THE ROLE OF PACKAGING IN A DEMANDING PHARMACEUTICAL LANDSCAPE
Ahead of this year’s Pharmapack Europe conference on Jan 21–22, 2026, Sherma Ellis Daal discusses the role of packaging and drug delivery systems in the wider pharmaceutical industry, offering insights on how key trends and pressures are changing thinking and redefining what makes a successful project.
DEVELOPMENTAL ADVANTAGES IN INJECTABLE COMBINATION DRUG PRODUCTS
EXPERT VIEW
Dr Oliver Eden
DEVELOPMENTAL ADVANTAGES IN INJECTABLE COMBINATION DRUG PRODUCTS
Oliver Eden and Travis Webb consider how regulatory considerations and patient-centric device designs are transforming the landscape of self-administered injectable drugs.
Interview: DARE IDDS – A Long-Term Subcutaneously Implanted Drug Delivery Device
INTERVIEW
Liz Proos
Daré Bioscience
Interview: DARE IDDS – A Long-Term Subcutaneously Implanted Drug Delivery Device
Liz Proos and Ashley Hawson talk exclusively with ONdrugDelivery's Guy Furness about the DARE Intelligent Drug Delivery System – an advanced, connected implantable device that delivers programmable doses for up to a decade – its place in the market, the challenges faced during its design and its potential as novel drug delivery device.
DESIGNING SUSTAINABLE DRUG DELIVERY DEVICE PACKAGING: TRENDS, CHALLENGES AND REGULATORY IMPLICATIONS
EXPERT VIEW
Angela Shotton
DESIGNING SUSTAINABLE DRUG DELIVERY DEVICE PACKAGING: TRENDS, CHALLENGES AND REGULATORY IMPLICATIONS
Angela Shotton and Nic Hunt, look at the evolving landscape of the pharmaceutical packaging landscape and consider how the industry is meeting sustainability and regulatory requirements.
FRACTIONAL INVESTMENT IN DEVICE PLATFORMS – A NEW FUNDING PARADIGM
EXPERT VIEW
Paul Jansen
FRACTIONAL INVESTMENT IN DEVICE PLATFORMS – A NEW FUNDING PARADIGM
Drawing on his extensive experience in the drug delivery device industry, Paul Jansen considers how funding for delivery device development has shifted over the years, from the pre-platform model to currently accepted practice and looks forward to how it may further evolve to support the development of novel devices in the biologics space and beyond.
THE PLATFORM PARADOX: DEVICE DEVELOPMENT CHALLENGES WITHIN FAST EVOLVING DRUG DISCOVERY PIPELINES
EXPERT VIEW
Tim Quigg
THE PLATFORM PARADOX: DEVICE DEVELOPMENT CHALLENGES WITHIN FAST EVOLVING DRUG DISCOVERY PIPELINES
Tim Quigg, Mariam Al-Amari and Joel Gresham discuss how to enable high-dose delivery for novel biologics, using ex vivo and in silico approaches to accelerate drug-device development and improve device performance, thus de-risking projects and saving costs.
FROM BRICK-DUST DRUGS TO BREAKTHROUGHS: TRANSFORMING DRUG DELIVERY WITH NOVEL EXCIPIENTS
FORMULATION
Dr Liliana Miinea
Lubrizol
FROM BRICK-DUST DRUGS TO BREAKTHROUGHS: TRANSFORMING DRUG DELIVERY WITH NOVEL EXCIPIENTS
Dr Liliana Miinea of Lubrizol discusses how next-generation excipients can help formulators realise the potential of promising but poorly soluble drug candidates, including Lubrizol’s Apisolex™ and Apinovex™ polymer excipients for parenteral and oral applications.
Top